)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Imugene
Imugene (IMU) investor relations material
Imugene Study update presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Study update presentation summary29 May, 2026
Study design and patient population
Phase 1/1b study enrolled 25 adults with relapsed/refractory CD19+ B-cell malignancies, all CAR T-naive and with a median of 2 prior therapies.
Eligible diseases included DLBCL, MZL, CLL, FL, PCNSL, WM, and PMBCL.
Recommended phase 2 regimen: 500M CAR T cells, lymphodepletion, and low-dose SC IL-2.
Technology and manufacturing
Azer-cel is an allogeneic, off-the-shelf CAR T therapy using ARCUS gene editing for precise CD19 CAR insertion into the TRAC locus.
Non-integrating AAV vector minimizes off-target editing and allows efficient delivery.
Efficacy outcomes
Objective response rate (ORR) was high across all indications, with 100% ORR in CLL and MZL, and 79% in DLBCL/RT.
ORR among patients with indolent disease was 93%.
Ongoing responses and molecular disease burden reduction observed in MZL and CLL cohorts.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Imugene
- Azer-cel showed robust efficacy in early trials, driving capital raises and strategic focus.IMU
Q3 2026 TU30 Apr 2026 - Net loss rose to $149.7M on higher R&D, with strong cash reserves and key clinical milestones ahead.IMUH2 202427 Mar 2026
- Net loss improved 54% year-over-year as clinical programs advanced and new funding was secured.IMUH2 202527 Mar 2026
- Net loss improved 22% to $37.8M, with strong clinical progress and ongoing funding needs.IMUH1 20268 Mar 2026
- Clinical progress and cost reductions drive outlook, but funding runway remains tight.IMUQ2 2026 TU8 Mar 2026
- Board changes, clinical advances, and financial strength drive strategic expansion in 2024.IMUAGM 202414 Jan 2026
- Promising clinical data and FDA Fast Track status drive focus on registrational studies and partnerships.IMUNWR Virtual Healthcare Conference26 Dec 2025
- FDA guidance de-risks azer-cel, enabling phase III entry and boosting commercial prospects.IMUFDA Meeting Update9 Dec 2025
- Azer-cel trials achieved 81% response rate; $24.9M raised, cash at $32.4M.IMUQ1 2026 TU7 Dec 2025
Next Imugene earnings date
H2 202624 Aug, 2026
Imugene
Next Imugene earnings date
H2 202624 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage